|
1
|
Bray F, McCarron P and Parkin DM: The
changing global patterns of female breast cancer incidence and
mortality. Breast Cancer Res. 6:229–239. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gupta GP and Massague J: Cancer
metastasis: building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dahiya R and Deng G: Molecular prognostic
markers in breast cancer. Breast Cancer Res Treat. 52:185–200.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ross JS and Fletcher JA: The HER-2/neu
oncogene in breast cancer: prognostic factor, predictive factor,
and target for therapy. Oncologist. 3:237–252. 1998.
|
|
5
|
Sgouros J, Galani E, Gonos E, et al:
Correlation of nm23-H1 gene expression with clinical outcome in
patients with advanced breast cancer. In Vivo. 21:519–522.
2007.PubMed/NCBI
|
|
6
|
Barnes DM and Gillett CE: Cyclin D1 in
breast cancer. Breast Cancer Res Treat. 52:1–15. 1998. View Article : Google Scholar
|
|
7
|
Wang H, Teh MT, Ji Y, et al: EPS8
upregulates FOXM1 expression, enhancing cell growth and motility.
Carcinogenesis. 31:1132–1141. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen YJ, Shen MR, Chen YJ, Maa MC and Leu
TH: Eps8 decreases chemosensitivity and affects survival of
cervical cancer patients. Mol Cancer Ther. 7:1376–1385. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Maa MC, Lee JC, Chen YJ, et al: Eps8
facilitates cellular growth and motility of colon cancer cells by
increasing the expression and activity of focal adhesion kinase. J
Biol Chem. 282:19399–19409. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang H, Patel V, Miyazaki H, Gutkind JS
and Yeudall WA: Role for EPS8 in squamous carcinogenesis.
Carcinogenesis. 30:165–174. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang W, Wang L, Liu Y, et al: Structure
of human lanthionine synthetase C-like protein 1 and its
interaction with Eps8 and glutathione. Genes Dev. 23:1387–1392.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Welsch T, Endlich K, Giese T, Buchler MW
and Schmidt J: Eps8 is increased in pancreatic cancer and required
for dynamic actin-based cell protrusions and intercellular
cytoskeletal organization. Cancer Lett. 255:205–218. 2007.
View Article : Google Scholar
|
|
13
|
Ding X, Zhou F, Wang F, et al: Eps8
promotes cellular growth of human malignant gliomas. Oncol Rep.
29:697–703. 2013.PubMed/NCBI
|
|
14
|
Kang H, Wilson CS, Harvey RC, et al: Gene
expression profiles predictive of outcome and age in infant acute
lymphoblastic leukemia: a Children’s Oncology Group study. Blood.
119:1872–1881. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Matoskova B, Wong WT, Salcini AE, Pelicci
PG and Di Fiore PP: Constitutive phosphorylation of eps8 in tumor
cell lines: relevance to malignant transformation. Mol Cell Biol.
15:3805–3812. 1995.PubMed/NCBI
|
|
16
|
Chu PY, Liou JH, Lin YM, et al: Expression
of Eps8 correlates with poor survival in oral squamous cell
carcinoma. Asia Pac J Clin Oncol. 8:e77–e81. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang TP, Chiou HL, Maa MC and Wang CJ:
Mithramycin inhibits human epithelial carcinoma cell proliferation
and migration involving downregulation of Eps8 expression. Chem
Biol Interact. 183:181–186. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gorsic LK, Stark AL, Wheeler HE, et al:
EPS8 inhibition increases cisplatin sensitivity in lung cancer
cells. PLoS One. 8:e822202013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Abdel-Rahman WM, Ruosaari S, Knuutila S
and Peltomaki P: Differential roles of EPS8 in carcinogenesis: loss
of protein expression in a subset of colorectal carcinoma and
adenoma. World J Gastroenterol. 18:3896–3903. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li YH, Xue TY, He YZ and Du JW: Novel
oncoprotein EPS8: a new target for anticancer therapy. Future
Oncol. 9:1587–1594. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yao J, Weremowicz S, Feng B, et al:
Combined cDNA array comparative genomic hybridization and serial
analysis of gene expression analysis of breast tumor progression.
Cancer Res. 66:4065–4078. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mangravite LM, Lipschutz JH, Mostov KE and
Giacomini KM: Localization of GFP-tagged concentrative nucleoside
transporters in a renal polarized epithelial cell line. Am J
Physiol Renal Physiol. 280:F879–F885. 2001.PubMed/NCBI
|
|
23
|
Schmid JA, Birbach A, Hofer-Warbinek R, et
al: Dynamics of NF kappa B and Ikappa Balpha studied with green
fluorescent protein (GFP) fusion proteins. Investigation of GFP-p65
binding to DNa by fluorescence resonance energy transfer. J Biol
Chem. 275:17035–17042. 2000. View Article : Google Scholar
|
|
24
|
Lois C, Hong EJ, Pease S, Brown EJ and
Baltimore D: Germline transmission and tissue-specific expression
of transgenes delivered by lentiviral vectors. Science.
295:868–872. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ding X, Yang Z, Zhou F, et al:
Transcription factor AP-2alpha regulates acute myeloid leukemia
cell proliferation by influencing Hoxa gene expression. Int J
Biochem Cell Biol. 45:1647–1656. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pan CC, Bloodworth JC, Mythreye K and Lee
NY: Endoglin inhibits ERK-induced c-Myc and cyclin D1 expression to
impede endothelial cell proliferation. Biochem Biophys Res Commun.
424:620–623. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ridley AJ: Rho GTPases and cell migration.
J Cell Sci. 114:2713–2722. 2001.PubMed/NCBI
|
|
28
|
Scita G, Tenca P, Areces LB, et al: An
effector region in Eps8 is responsible for the activation of the
Rac-specific GEF activity of Sos-1 and for the proper localization
of the Rac-based actin-polymerizing machine. J Cell Biol.
154:1031–1044. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Scita G, Nordstrom J, Carbone R, et al:
EPS8 and E3B1 transduce signals from Ras to Rac. Nature.
401:290–293. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen H, Wu X, Pan ZK and Huang S:
Integrity of SOS1/EPS8/ ABI1 tri-complex determines ovarian cancer
metastasis. Cancer Res. 70:9979–9990. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hecquet C, Lefevre G, Valtink M, Engelmann
K and Mascarelli F: Activation and role of MAP kinase-dependent
pathways in retinal pigment epithelial cells: ERK and RPE cell
proliferation. Invest Ophthalmol Vis Sci. 43:3091–3098.
2002.PubMed/NCBI
|
|
32
|
Chang F, Steelman LS, Lee JT, et al:
Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from
cytokine receptors to transcription factors: potential targeting
for therapeutic intervention. Leukemia. 17:1263–1293. 2003.
View Article : Google Scholar
|
|
33
|
McCawley LJ, Li S, Wattenberg EV and
Hudson LG: Sustained activation of the mitogen-activated protein
kinase pathway. A mechanism underlying receptor tyrosine kinase
specificity for matrix metalloproteinase-9 induction and cell
migration. J Biol Chem. 274:4347–4353. 1999. View Article : Google Scholar
|
|
34
|
Oren M: Decision making by p53: life,
death and cancer. Cell Death Differ. 10:431–442. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Thiery JP: Epithelial-mesenchymal
transitions in development and pathologies. Curr Opin Cell Biol.
15:740–746. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Grunert S, Jechlinger M and Beug H:
Diverse cellular and molecular mechanisms contribute to epithelial
plasticity and metastasis. Nat Rev Mol Cell Biol. 4:657–665. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Onder TT, Gupta PB, Mani SA, et al: Loss
of E-cadherin promotes metastasis via multiple downstream
transcriptional pathways. Cancer Res. 68:3645–3654. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tanaka H, Kono E, Tran CP, et al:
Monoclonal antibody targeting of N-cadherin inhibits prostate
cancer growth, metastasis and castration resistance. Nat Med.
16:1414–1420. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lang SH, Hyde C, Reid IN, et al: Enhanced
expression of vimentin in motile prostate cell lines and in poorly
differentiated and metastatic prostate carcinoma. Prostate.
52:253–263. 2002. View Article : Google Scholar : PubMed/NCBI
|
